The Sino-US Puan International Cancer Hospital project signing ceremony was held in the Qingdao west coast new area on the 23rdof March. The project, which was invested and built jointly by the US FCCC, Qingdao city investment group, and Beijing ZhongjinpuanInvestment Company, aims to build itself intoanational oncotherapy model city. It will establish the 1st gene anti-body and immunotherapy technologies 10,000-grade clean lab in the Asia-Pacific area. The total investment of the project reaches CNY 2.35 billion.

    Covering an area of 150,000sqm, the project is going to build an internationalized, high-end and personalized oncotherapy medical institute. The center will leverage expert resources of US FCCC, UK highland university tumor immunology research center, Top Grade Sweden radiation tumor research institute, and introduce world-leading scintillation shooting and single photon emission tomography technologies, together with accurate targeting therapy and gene therapy technologies. (Wang Kai)